Non-opioid pain treatment is the complementary to the opioid treatment which are progressively used for mild to moderate pain treatment. These are robust in nature and has fewer side effects.
According to Report Ocean study, Global Non-Opioid Pain Treatment Market was approximately USD 13.8 million in 2019 and is anticipated to grow at a rate of more than 18% over the forecast period 2020-2027.
GET SAMPLE COPY @ https://www.reportocean.com/industry-verticals/sample-request?report_id=bw1404
This report forecasts growth of Non-Opioid Pain Treatment Market at global level and provides an insight of the latest trends. For the current analysis, Report Ocean has segmented the market by product and by application.
By Product
- Medical Cannabis
- Menthol-Containing
- Omega 3 Fatty Acid-Containing
- Botulinum Toxins
- Capsaicin-Derived
By Application
- Cancer pain
- orthopaedic and musculoskeletal pain
- Neuropathic pain
The accelerating addiction for opioid drugs leads to opioid epidemic in November, 2017 in The United States, thus many countries tried to search for an alternative which are safer and effective. Moreover, growing awareness related to the opioid drugs and its adverse outcomes. These facts alleviate the non-opioid pain treatment market globally. Contrary to this, the availability of unauthorized products and alternative therapies restrains the market growth.
The botulinum toxin has analgesic effect by reducing muscular hyperactivity. According to the International Agency for Research on Cancer (IARC), approximately 17.0 million cases of cancer were registered in 2018 and over 9.5 million cancer deaths globally. Also, data from the IARC showed the prevalence of cancer is expected to rise over 27.5 million cases and 16.3 million death in the upcoming years.
The key regions taken into consideration for the study and analysis of the global Non-Opioid Pain Treatment market are Asia Pacific, North America, Europe, Latin America, and Rest of the World. The leading country with relevant research funding, numerous manufacturers along with ongoing clinical trials is the North America. On the other hand, Asia-Pacific with the increasing prevalence of chronic diseases is expected to grow over the forecast period 2020-2027.
Major market players of non-opioid treatment included in this report are US Worldmeds LLC, Baudax Bio, GW Pharmaceuticals, plc, Allergan plc, Cronos Group, Medropharm Gmbh and others.
Marketed Products
Orphengesic Forte is non-opioid drug consisting of orphenadrine citrate, aspirin and caffeine. It has been developed by Galt Pharmaceuticals and received the FDA approval in July, 2020. It blocks the facilitatory functions in the brain central stem.
Anjeso developed by Baudax Bio received the Food and Drug Administration approval in February, 2020. It is a monotherapy administered intravenously. This COX-2 inhibitor has been designed as non-opioid pain management drug.
LUCEMYRA™ (lofexidine), developed by US WorldMeds, LLC in collaboration with Salix Pharmaceuticals is used for opioid withdrawal symptoms to support abrupt opioid discontinuation in adults. It is a central alpha 2-adrenergic agonist that lowers the release of norepinephrine and is administered orally. The drug was approved by the FDA in August, 2018.
Dyloject, designed by Hospira is a non-steroidal, anti-inflammatory non-opioid drug. It was approved by the FDA back in 2014. The underlying mechanisms are the inhibition of the cyclooxygenase (COX-1 and COX-2) pathways or the inhibition of prostaglandin synthetase. It is intravenously administered injection.
Impact of Covid-19 on Non-Opioid Pain Treatment Market
Although pain treatment has been one of the fundamental healthcare markets, the Coronavirus disease 2019 (COVID-19) pandemic has made the redistribution of healthcare resources towards the sites dedicated for the care of patients suffering from COVID-19 or are at risk. The distinctive features of pain management market are face to face delivery of services or an in-person visit for consultancy. This has faced major breakthrough due to the lockdown imposed by the government and social distancing measures to avoid the spread of coronavirus. Telehealth and telemedicine have been suggested for chronic pain patients.
Have Any Query? Ask Our Experts: https://www.reportocean.com/industry-verticals/sample-request?report_id=bw1404
About Report Ocean:
We are the best market research reports provider in the industry. Report Ocean believe in providing the quality reports to clients to meet the top line and bottom line goals which will boost your market share in today’s competitive environment. Report Ocean is “one-stop solution” for individuals, organizations, and industries that are looking for innovative market research reports.
Get in Touch with Us:
Report Ocean
Name: Nishi Sharma
Email: sales@reportocean.com
Address: 500 N Michigan Ave, Suite 600, Chicago, IIIinois 60611 – UNITED STATES
Tel: +1 888 212 3539 (US – TOLL FREE)
Website: https://www.reportocean.com/
